In vivo, WX-UK1 inhibited the proteolytic activity of uPA and plasmin in mice and reduced tumor growth and metastasis [129], perhaps by inhibiting plasmin-mediated ECM proteolysis and MMP activation. Here, PLAU is linked to neoplasm.